Curegenix was founded by scientists from top US biopharma and universities in 2009. Our long-term goal is to build a world-class drug discovery company. To achieve this goal, we employed world-leading science / technology and established a unique drug screening platform. Using this platform, we have explored a number of novel drug targets and discovered new chemical entities with world-wide intellectual property rights for the treatment of serious illnesses such as cancer and fibrosis. After several years of hard work, our achievements have been recognized by the investment community and the pharmaceutical industry. In 2013, Curegenix received funding from Cenova Ventures, a leading venture capital firm in the domain. In 2014, our GI cancer project won a national priority "Drug Discovery Project" award.
| Website | http://www.curegenix.com |
| Revenue | $5 million |
| Employees | 1 (1 on RocketReach) |
| Address | 332 Beach Rd, Burlingame, California 94010, US |
| Phone | (650) 743-5297 |
| Fax | (650) 343-1889 |
| Industry | Chemicals, Petrochemicals, Glass & Gases, Manufacturing |
| Competitors | Pfizer, Amgen, AstraZeneca, Gilead Sciences, Johnson & Johnson, Genentech, Regeneron, CureVac, Novavax, Moderna Therapeutics +36 more (view full list) |
| SIC | SIC Code 20 Companies, SIC Code 208 Companies |
| NAICS | NAICS Code 31214 Companies, NAICS Code 3121 Companies, NAICS Code 312 Companies, NAICS Code 31 Companies |
Looking for a particular Curegenix Inc employee's phone or email?
Curegenix Inc Questions
The Curegenix Inc annual revenue was $5 million in 2026.
1 people are employed at Curegenix Inc.
Curegenix Inc is based in Burlingame, California.
The NAICS codes for Curegenix Inc are [31214, 3121, 312, 31].
The SIC codes for Curegenix Inc are [20, 208].
